D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
BENIGNO P and MONACO P [Analysis of the sedative effect exerted by 1,4-amino-3-isoxazolidone]. 1960 Arch Int Pharmacodyn Ther pmid:13798880
LANGE P and OEHME P [CENTRAL NERVOUS EFFECTS OF D- AND D,1-CYCLOSERINE]. 1964 Arch Int Pharmacodyn Ther pmid:14265664
Jotti D et al. [Antitubercular therapy in pregnancy in relation to possible injurious effects on gestation and the fetus]. 1968 May-Jun Arch Maragliano Patol Clin pmid:5755412
Scarponi F and Dorigoni A [Preliminary experiences with treatment of pulmonary tuberculosis with 1',4'-bis-D-(3-oxo-4-isoxazolidinyliminomethyl)-benzene (Terizidone)]. 1968 Jul-Aug Arch Maragliano Patol Clin pmid:5755799
POGGIO G and ALCOZER G [Cycloserine in the treatment of pulmonary tuberculosis. Review of the literature and casuistic contribution]. 1960 Arch Maragliano Patol Clin pmid:13736540
Werner D [The life cycle with sexual phase in the marine diatom Coscinodiscus asteromphalus. II. Surface-dependant differentiation during the vegetative cell diminution]. 1971 Arch Mikrobiol pmid:5129216
PLAPP R and KANDLER O [ON THE EFFECT OF ANTIBIOTICS INHIBITING THE CELL WALL ON GRAM-NEGATIVE BACTERIA. II. THE EFFECT OF D-CYCLOSERINE ON THE CONCENTRATION OF CELL WALL PRECURSORS IN PROTEUS MIRABILIS AND ITS L-PHASE]. 1965 Arch Mikrobiol pmid:14262418
PRADO-TORTEROLO JM and VICECONTI G [TUBERCULOUS MENINGITIS. DIAGNOSTIC ASPECTS. EXTRATHECAL TREATMENT EXCLUSIVELY. CURE]. 1963 Arch Pediatr Urug pmid:14103317
Panijayanond P et al. Intraocular nocardiosis in a renal transplant patient. 1972 Arch Surg pmid:4555181
Nitti V et al. [Activity of terizidone in experimental tuberculosis in rabbits]. 1969 Arch Tisiol Mal Appar Respir pmid:5315045
BLASI A et al. [The action of cycloserine in experimental tuberculosis (Comparative studies between the histologic aspects and the level of concentration in the tissues)]. 1959 Arch Tisiol Mal Appar Respir pmid:13801355
ZUBIANI M and LUCCHESI M [BACTERIOLOGICAL FINDINGS IN SUBJECTS AFFECTED BY CHRONIC PULMONARY TUBERCULOSIS (FINDINGS ON PATIENTS HOSPITALIZED IN THE ISTITUTO "C. FORLANINI" IN THE 3 YEAR PERIOD 1960-62)]. 1964 Arch Tisiol Mal Appar Respir pmid:14253925
Garmy N et al. Apical uptake and transepithelial transport of sphingosine monomers through intact human intestinal epithelial cells: physicochemical and molecular modeling studies. 2005 Arch. Biochem. Biophys. pmid:16009329
Meyer SG and de Groot H [14C]serine from phosphatidylserine labels ceramide and sphingomyelin in L929 cells: evidence for a new metabolic relationship between glycerophospholipids and sphingolipids. 2003 Arch. Biochem. Biophys. pmid:12559982
Veerkamp JH The structure of the cell wall peptidoglycan of Bifidobacterium bifidum var. pennsylvanicus. 1971 Arch. Biochem. Biophys. pmid:4254496
NEILANDS JB Metal and hydrogen-ion binding properties of cycloserine. 1956 Arch. Biochem. Biophys. pmid:13314649
Frecking MG and Hoeprich PD Effect of cycloserines on D-amino acid oxidase. 1966 Arch. Biochem. Biophys. pmid:4381739
Yoshida T and Kikuchi G Significance of the glycine cleavage system in glycine and serine catabolism in avian liver. 1971 Arch. Biochem. Biophys. pmid:4108152
HOWLETT KS and WARRING FC RESPONSE TO TREATMENT IN SILICOTUBERCULOSIS; A TEN-YEAR SURVEY. 1964 Arch. Environ. Health pmid:14172785
FOUQUET J and CORNU P [TUBERCULOUS MENINGITIS WITH RESISTANT KOCH BACILLI; RECOVERY OWING TO CYCLOSERINE-PYRAZINAMIDE COMBINATION]. 1964 Arch. Fr. Pediatr. pmid:14248329
Ressler KJ et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. 2004 Arch. Gen. Psychiatry pmid:15520361
Hofmann SG et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. 2006 Arch. Gen. Psychiatry pmid:16520435
Farber NB et al. Glycine agonists: what can they teach us about schizophrenia? 1999 Arch. Gen. Psychiatry pmid:9892251
Goff DC et al. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. 1999 Arch. Gen. Psychiatry pmid:9892252
Greene R et al. Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction. 2000 Arch. Gen. Psychiatry pmid:11115333
HOEPRICH PD ALANINE: CYCLOSERINE ANTAGONISM. II. SIGNIFICANCE OF PHENOMENON TO THERAPY WITH CYCLOSERINE. 1963 Arch. Intern. Med. pmid:14045288
Haden HT Pyridoxine-responsive sideroblastic anemia due to antituberculous drugs. 1967 Arch. Intern. Med. pmid:6054596
Whitfield CL Hematologic abnormalities in tuberculous patients. 1970 Arch. Intern. Med. pmid:5506972
Kitani S et al. Control of secondary metabolism by farX, which is involved in the gamma-butyrolactone biosynthesis of Streptomyces lavendulae FRI-5. 2010 Arch. Microbiol. pmid:20131045
Venir E et al. Involvement of alanine racemase in germination of Bacillus cereus spores lacking an intact exosporium. 2014 Arch. Microbiol. pmid:24346000
Moridani M and Scott T Lookalike, soundalike tests: preventing serious medical errors. 2013 Arch. Pathol. Lab. Med. pmid:23276168
Li X et al. Original and efficient synthesis of D-cycloserine. 2010 Arch. Pharm. (Weinheim) pmid:20803624
Kang BY et al. Genomic fingerprinting of antituberculosis agents-resistant Lactobacillus ruminus SPM0211 using the Microbial Uniprimer kit. 2005 Arch. Pharm. Res. pmid:16114501
ROGNATO C [Cycloserine and its use in pulmonary tuberculosis]. 1959 Arcisp S Anna Ferrara pmid:14438397
ROGNATO C [Electrophoretic picture, serum agglutinins, sedimentation rate and allergometry during cycloserine treatment. 5]. 1959 Arcisp S Anna Ferrara pmid:14438398
BUGIARDINI G et al. [Urinary elimination of 17-ketosteroids in subjects treated with cycloserine]. 1959 Arcisp S Anna Ferrara pmid:13849226
ROGNATO C et al. [Hematic levels of cycloserine in relation to seasonal temperature]. 1959 Arcisp S Anna Ferrara pmid:13854547
ROGNATO C and ZAMPINI N [Urinary elimination of cycloserine in man]. 1959 Arcisp S Anna Ferrara pmid:13854548
MARIANO J [Therapeutic trial of Serocycline in leprosy]. 1961 Arq Min Leprol pmid:14469808
Worgall TS et al. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15132973
Mattila MJ et al. Drug absorption in patients with intestinal villous atrophy. 1973 Arzneimittelforschung pmid:4740240
HANTSCHMANN L and SCHWAB M [On the treatment of tuberculosis with cycloserine in hospitals]. 1960 Arzneimittelforschung pmid:14399637
Pallanza R et al. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. 1967 Arzneimittelforschung pmid:5631580
Mayer G and Schwabe HK [Effect of cycloserine in vitro on cortisone degradation in rat liver]. 1966 Arzneimittelforschung pmid:6014745
Glass F et al. [Observations and studies on the joint effects of alcohol and D-cycloserine]. 1965 Arzneimittelforschung pmid:5899248
Mattila MJ et al. Modification by sodium salicylate and paraaminosalyicylic acid of the protein binding and antimycobacterial effect of isoniazid in vitro. 1972 Arzneimittelforschung pmid:4197739
Urbanczik R [The effect on sublethal terizidon concentration on the mutation rate for streptomycin- and rifampicin resistance in E. coli]. 1974 Arzneimittelforschung pmid:4603888
Thong BY Clinical applications of drug desensitization in the Asia-Pacific region. 2011 Asia Pac Allergy pmid:22053290
Sogebi OA et al. Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy. 2017 Auris Nasus Larynx pmid:27832910
Wetherall JD et al. The rat mast cell degranulation assay as an in vitro allergy test. 1974 Aust N Z J Med pmid:4137996
Beck AD The treatment of renal tuberculosis. 1969 Aust N Z J Surg pmid:4977937
Dall'Olio R et al. An ionotropic but not a metabotropic glutamate agonist potentiates the pharmacological effects of olanzapine in the rat. 2005 Behav Pharmacol pmid:16286815
Dall'Olio R et al. D-Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic function. 2000 Behav Pharmacol pmid:11198134
Gaiardi M et al. Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine. 2001 Behav Pharmacol pmid:11710746
Gaiardi M et al. D-cycloserine inhibits the development and the expression of locomotor sensitization to amphetamine in rats. 2010 Behav Pharmacol pmid:20445441
Depoortere R et al. Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex. 1999 Behav Pharmacol pmid:10780302
Sakurai S et al. Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats. 2007 Behav Pharmacol pmid:17762518
Guastella AJ et al. A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. 2007 Behav Res Ther pmid:16962066
Norrholm SD et al. Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. 2016 Behav Res Ther pmid:27183343
Meuret AE et al. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. 2016 Behav Res Ther pmid:27070526
Chasson GS et al. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine. 2010 Behav Res Ther pmid:20362975
Rapee RM et al. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders. 2016 Behav Res Ther pmid:27771572
Hofmann SG Enhancing exposure-based therapy from a translational research perspective. 2007 Behav Res Ther pmid:17659253
George SA et al. D-Cycloserine Facilitates Reversal in an Animal Model of Post-traumatic Stress Disorder. 2018 Behav. Brain Res. pmid:29580893
Sugiyama A et al. Administration of riluzole to the basolateral amygdala facilitates fear extinction in rats. 2018 Behav. Brain Res. pmid:28843863
Hughes RN Responsiveness to brightness change in male and female rats following treatment with the partial agonist of the N-methyl-D-aspartate receptor, D-cycloserine. 2004 Behav. Brain Res. pmid:15196787
Botreau F et al. d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. 2006 Behav. Brain Res. pmid:16769132
Ho YJ et al. Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia. 2011 Behav. Brain Res. pmid:21262271
Norris JN et al. Posttrial d-cycloserine enhances the emotional memory of an incentive downshift event. 2011 Behav. Brain Res. pmid:21596065
Andersen JM et al. Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats. 2002 Behav. Brain Res. pmid:11809513
Thanos PK et al. D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice. 2009 Behav. Brain Res. pmid:19152811
Assini FL et al. Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation. 2009 Behav. Brain Res. pmid:19523494
Kranjac D et al. Peripheral administration of D-cycloserine rescues memory consolidation following bacterial endotoxin exposure. 2013 Behav. Brain Res. pmid:23295393
Villarejo-Rodríguez I et al. D-cycloserine in prelimbic cortex enhances relearning of an odor-reward associative task. 2010 Behav. Brain Res. pmid:20399234
Wang AL et al. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats. 2010 Behav. Brain Res. pmid:19900486
Villarejo-Rodríguez I et al. Learning deficits in an odor reward-task induced by parafascicular thalamic lesions are ameliorated by pretraining D-cycloserine in the prelimbic cortex. 2013 Behav. Brain Res. pmid:23124092
Sugiyama A et al. Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat. 2017 Behav. Brain Res. pmid:28359884
Ortiz V et al. Effect of a positive reinforcing stimulus on fear memory reconsolidation in ethanol withdrawn rats: Influence of d-cycloserine. 2016 Behav. Brain Res. pmid:27522017
Wisłowska-Stanek A et al. Effects of D-cycloserine and midazolam on the expression of the GABA-A alpha-2 receptor subunits in brain structures of fear conditioned rats. 2011 Behav. Brain Res. pmid:21889957
Sierra RO et al. Medial orbitofrontal cortex lesion prevents facilitatory effects of d-cycloserine during fear extinction. 2016 Behav. Brain Res. pmid:26306827
Sarıdoğan GE et al. D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model. 2015 Behav. Brain Res. pmid:26225843
Wu SL et al. Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels. 2008 Behav. Brain Res. pmid:17959260
Philbert J et al. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine. 2015 Behav. Brain Res. pmid:25446760
Gomes FV et al. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats. 2014 Behav. Brain Res. pmid:24931794
Fishkin RJ et al. D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. 1993 Behav. Neural Biol. pmid:8476382
Thompson LT and Disterhoft JF Age- and dose-dependent facilitation of associative eyeblink conditioning by D-cycloserine in rabbits. 1997 Behav. Neurosci. pmid:9438799
Woods AM and Bouton ME D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. 2006 Behav. Neurosci. pmid:17014266
Ledgerwood L et al. D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. 2004 Behav. Neurosci. pmid:15174928
Vurbic D et al. Effects of D-cycloserine on the extinction of appetitive operant learning. 2011 Behav. Neurosci. pmid:21688894
Rodgers RJ et al. D-cycloserine enhances memory consolidation in the plus-maze retest paradigm. 2011 Behav. Neurosci. pmid:21319892
Ledgerwood L et al. Effects of D-cycloserine on extinction of conditioned freezing. 2003 Behav. Neurosci. pmid:12708530
Eidus L [Control methods for the demonstration in the urine of tuberculostatic drugs of secondary importance]. 1968 Beitr Klin Erforsch Tuberk Lungenkr pmid:5712001
Simon K [Prophylactic and preventive measures in the fight against tuberculosis]. 1968 Beitr Klin Erforsch Tuberk Lungenkr pmid:5748058
Rosenfeld M [Chemotherapy of so-called atypical mycobacterioses]. 1968 Beitr Klin Erforsch Tuberk Lungenkr pmid:4195733
SERI I [On the evaluation of antitubercular agents of second rank]. 1960 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:13750236
TITZE B [Clinical-roentgenological results in therapy of pulmonary tuberculosis with D-cycloserine]. 1959 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:13838533
KALICH R et al. [DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST]. 1965 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:14273020
FERLINZ R [Clinical studies on the combined treatment of pulmonary tuberculosis with corticosteroids and cycloserine]. 1963 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:13944768
WIESNER B [THE EFFECT OF NEW TUBERCULOSTATICS ON THE BLOOD COAGULATION]. 1964 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:14316861
MEISSNER G [On cycloserine]. 1963 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:13934605